A study to evaluate the effect of Dushivishari Agad tablets orally and Arjuntwak Churna for facepack in the treatment of Melasma.

A single-arm clinical study to evaluate the efficacy of Dushivishari Agad orally and Arjuntwak churna lepa in the management of Vyanga with special reference to Melasma - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088782

Enrollment

Registered

2025-06-13

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L811- Chloasma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: pts comimg to Sane Guruji Arogya Kendra having Sign and Symptoms of Vyanga (Melasma) will be selected irrespective of their gender , community, caste and economic status

Exclusion criteria

Exclusion criteria: 1. Patient with present and past history of any skin diseases like psoriais, eczema. 2. Pregnant and lactating women . 3. Patients having Hyperpigmentation due to Addisons Diseases, cushings Diseases. Already Diagnosed Thyroid Diseases.

Design outcomes

Primary

Measure	Time frame
MASI SCALE GRADE SCALE To evaluate the efficacy of Dushivishari Agad orally and Arjun Twak churna lep in the management of Vyanga with special reference to melasmaTimepoint: baseline 15th day 30th day 45th day and 60th day	—

Secondary

Measure	Time frame
To observe adverse effect of Dushivishari Agad and Arjunchurna lepaTimepoint: baseline 15th day 30th day 45th day 60th day	—

Countries

India

Contacts

Public ContactDr Vidya Undale Newaskar

MAMs Sumatibhai Shah Ayurveda Mahavidyalaya Malwadi Hadapsar Pune

undale.vidya@gmail.com9422345801

Outcome results